The Indian primary market is taking a brief pause. After a busy period of mainboard IPOs, the coming week will be quieter. No large company offerings are scheduled. However, three Small and Medium Enterprise (SME) issues will open for subscription. This keeps the market active.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,